The hypothesis led by Ix et al. suggests that fetuin-A, by acting as a physiological tyrosine kinase inhibitor, can lead to hyperlipidemia through decreased insulin activity, resulting in increased lipolysis in the adipose tissue. This evidence concerns the gene INS and hyperlipidemia.